Non-redundant activity of GSK-3α and GSK-3β in T cell-mediated tumor rejection

Autor: Aarren J. Mannion, Alison Taylor, Gary Shaw, Christopher E. Rudd, Kenneth A. MacLennan, Graham P. Cook, Lynette Steele
Rok vydání: 2021
Předmět:
Zdroj: iScience, Vol 24, Iss 6, Pp 102555-(2021)
iScience
ISSN: 2589-0042
Popis: Summary Glycogen synthase kinase-3 (GSK-3) is a positive regulator of PD-1 expression in CD8+ T cells and GSK-3 inhibition enhances T cell function and is effective in the control of tumor growth. GSK-3 has two co-expressed isoforms, GSK-3α and GSK-3β. Using conditional gene targeting, we demonstrate that both isoforms contribute to T cell function to different degrees. Gsk3b−/− mice suppressed tumor growth to the same degree as Gsk3a/b−/− mice, whereas Gsk3a−/− mice behaved similarly to wild-type, revealing an important role for GSK-3β in regulating T cell-mediated anti-tumor immunity. The individual GSK-3α and β isoforms have differential effects on PD-1, IFNγ, and granzyme B expression and operate in synergy to control PD-1 expression and the infiltration of tumors with CD4 and CD8 T cells. Our data reveal a complex interplay of the GSK-3 isoforms in the control of tumor immunity and highlight non-redundant activity of GSK-3 isoforms in T cells, with implications for immunotherapy.
Graphical abstract
Highlights • Conditional knockouts reveal a non-redundant role for GSK-3α and GSK-3β in T cells. • GSK-3α and GSK-3β act together to enhance PD-1 expression. • GSK-3β depletion alone enhances T cell mediated tumor rejection. • GSK-3β plays an important role in regulating T cell-mediated anti-tumor immunity.
Cancer; Cell biology; Functional aspects of cell biology; Immunology
Databáze: OpenAIRE